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Abstract 
Article History 
 
The aim of this present study was to investigate the antimicrobial, antioxidative and 
antilymphoproliferative activity of the isolated new INDIN-SAA protein from the roots of B. 
diffusa against the disease scrofula adenitis caused by Mycobacterium scrofulaceum. Total 
antioxidant capacity assay showed that purified protein fraction (PPF) show stronger 
antioxidant activity (3.15 fold vs CPE-1.34 fold vs PPPE), than partially purified protein 
fraction (PPPF) and crude protein extract (CPE), respectively. The antimicrobial activity of 
the isolated CPEs and its PPFs on the pathogen M. scrofulaceum was evaluated on the 
basis of inhibition zone (IZ) using hole diffusion method, the minimal inhibitory concentration 
(MIC) and bacterial growth curve inhibition. The data showed that significant antimicrobial 
and antioxidative effect of the crude protein and its purified fractions against microorganism 
(M. scrofulaceum). Thus the result of this study could provide efficacious and cost effective 
treatment of the disease (Scrofula adenitis) without any cytotoxic effects. 
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Introduction 
Scrofula adenitis (Anjeerbal, Scrophula or Struma) is the 
term used for tuberculosis of the neck, or, more precisely, a 
cervical tuberculous lymphadenopathy [1]. Scrofula is usually a 
result of an infection in the lymph nodes, known as 
lymphadenitis and is most often observed in 
immunocompromised patients (about 50% of cervical 
tuberculous lymphadenopathy). About 95% of the scrofula 
cases in adults are caused by Mycobacterium tuberculosis, but 
only 8% of cases in children. The rest are caused by atypical 
mycobacterium (Mycobacterium scrofulaceum) or 
nontuberculous mycobacterium (NTM). With the stark 
decrease of tuberculosis in the second half of the 20th century, 
scrofula became a very rare disease. With the appearance of 
AIDS, however, it has shown resurgence and presently affects 
about 5% of severely immunocompromised patients [2]. The 
most usual signs and symptoms are the appearance of a 
chronic, painless mass in the neck, which is persistent and 
usually grows with time. The mass is referred to as a "cold 
abscess", because there is no accompanying local colour or 
warmth and the overlying skin acquires a violaceous (bluish-
purple) colour. NTM infections do not show other notable 
constitutional symptoms, but scrofula caused by tuberculosis is 
usually accompanied by other symptoms of the disease, such 
as fever, chills, malaise and weight loss in about 43% of the 
patients. As the lesion progresses, skin becomes adhered to 
the mass and may rupture, forming a sinus and an open 
wound. Boerhaavia diffusa (Punarnava) belonging to the 
Nyctaginaceae family, is mainly diffused perennial herbaceous 
creeping weed of India and Brazil and used extensively in liver 
and kidney disorders. The roots of B. diffusa contains alkaloids 
(punarnavine), rotenoids (boeravinones A-F), flavonoids, 
amino acids, lignins (liriodendrons), β-sitosterols and 
tetracosanoic, esacosanoic, srearic and ursolic acids.The roots 
of B. diffusa is used for the treatment of many diseases, such 
as anti-inflammatory [3, 4], diuretic [5], laxative [6], anti-
urethritis [7], anticonvulsant [8], antinematodal, antifibrinolytic 
[9], antibacterial [10], antithepatotoxy [11, 12, 13], anthelmintic, 
febrifuge, antileprotic, anti-ashmatic, blood impurities, anaemia  
jaundice, enlargement of spleen, abdominal pain, 
anticarcinogenic, antiscabby and antistress activities. The 
aqueous extract of Boerhaavia diffusa has protected mice 
against E. coli induced peritonitis based on its 
immunomodulatory activity. Singh and Udupa [14] reported 
that the dried root powder showed curative efficiency when 
administered orally for one month to the children or adults 
suffering from the helminth infection. An aqueous extract of 
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thinner roots of Boerhaavia diffusa at a dose of 2 mg/kg 
exhibited the remarkable protection of various enzymes such 
as serum glutamate oxaloacetate transaminase, serum 
glutamate pyruvate transaminase and bilirubin in serum 
against hepatic injury in rats [13]. Maximum diuretic and anti-
inflammatory activities of Punarnava have been observed in 
samples collected during the rainy seasons. Due to the 
combination of these two activities, Punarnava is regarded 
therapeutically highly efficacious for the treatment of renal 
inflammatory disease and common clinical problems such as 
nephritic syndrome, oedema, and ascites developing at the 
early onsets of the liver cirrhosis and chronic peritonitis. The 
treatment with the watery extract from the root of Boerhaavia 
diffusa induced leucocytosis with predominant neutrophils, 
associated to the phagocytosis ability and it was bactericidal to 
the neutrophils and the macrophages [15]. The recent study 
[16] demonstrated that the levels of Boerhaavia diffusa 
reduced the levels of glucose in the blood increasing the 
insulin release from β-cells of pancreas. The watery extract of 
Boerhaavia diffusa was proved to possess protective abilities 
to the rodents suffering from the peritonitis induced by 
Escherichia coli [17]. It was evidenced that the leaves and root 
possessed antifibrinolytic and anti-inflammatory activities [17]. 
The ethanolic extract of Boerhaavia diffusa showed a 
significant immunosuppressive activity on human cells and on 
murine cells as well [18]. The world wide use of Boerhaavia 
diffusa for various liver disorders, hypolipidemic, 
hypoglycaemic and antilymphoproliferative activity has been 
reported [18, 16]. 
Material and Methods 
Plant Material:-The samples of the roots of Boerhaavia diffusa 
(Nyctaginaceae), collected in Aligarh (UP) were kindly provided 
by Prof. Siddiqui (Taxonomist), Department of Botany, Aligarh 
Muslim University, Aligarh, India and the voucher specimen 
(AMUBT8977) has been preserved in our research laboratory 
(Dept. of Biochemistry, J.N. Medical College, AMU, Aligarh) for 
future reference in research. 
Preparation of Plant Extract:-Dried roots of Boerhaavia 
diffusa (377 g) were chopped into small pieces and sterilized. 
Roots were crushed in 500 ml of extraction buffer containing 
1M NaCl, 1M Sucrose, 0.2 M Acetate Buffer pH 5.0, 0.1 M 
EDTA pH 8.0, β-mercaptoethanol 200 µl and 50 ml of distilled 
water mixed together. The tissue homogenate was filtered 
through four layer of cheese cloth and centrifuged at 9500 rpm 
for 30 min. The clear supernatant was referred as crude 
protein, unless stated otherwise the supernatant was stored at 
40C. 
Characterization and estimation of isolated crude protein: 
Protein (INDIN-SAA) present in the crude extract of roots was 
fractionated by ammonium sulphate precipitation [19]. The 
protein precipitating at 0-80% saturation of ammonium 
sulphate were separated from the supernatant by 
centrifugation at temperature 40C, 9000 rpm for 1 hour. The 
pellet thus obtained were dissolved in 2 ml of sodium acetate 
buffer, pH 5.0 and partially purified protein were stored at 40C 
until used. Further protein assay was done [20], using Bovine 
Serum Albumin (BSA) as a standard. 
Microorganism:-The pure culture of Mycobacterium 
scrofulaceum which was a generous gift from Dr. M. S. Khan, 
Integral University, Lucknow, UP, was maintained at 40C until 
use. The Mycobacterium scrofulaceum culture was activated at 
370C for 24 hours on Nutrient Agar media (NAM) prior to 
screening. The Muller Hinton Agar (MHA) and the nutrient 
broth were used for antimicrobial assay. The plates inoculated 
with Mycobacterium scrofulaceum were than incubated at 370C 
for 24 hours. Antimicrobial activity was evaluated by measuring 
the diameters of hole and zone of growth inhibition around the 
hole. The assay was repeated on three plates and mean 
diameter was recorded as given below 
Area of growth zone inhibition= π (r22-r12) 
Where r2= radius from centre to periphery of growth zone 
           r1= radius from centre to periphery of hole, π = 3.14 
Minimal Inhibitory Concentration (MIC) determination by 
hole diffusion method 
Further 10 fold serially decreasing dilutions of all the three 
fractions were done. So the curve should be in the range of 5-
1000 µg/ml. Each dilution was tested by hole diffusion method 
as described earlier and MIC determined as the lowest 
concentration of proteins that can show a visible inhibition 
zone.  
Statistical Evaluation 
Statistical analysis of data was done by employing two 
tailed student t-test as described [21]. P values less than 0.05 
were considered significant. 
Antioxidant Activity 
Measurement of plasma “total antioxidant power” (FRAP) 
The method [22] was used for measuring the ferric 
reducing ability, the FRAP assay, which estimate the “total 
antioxidant power”, with minor modification. Ferric to ferrous 
ion reduction at low pH results in the formation of a colored 
ferrous-tripyridyl triazine complex. The assay was carried out in 
a total volume of 1.0 ml containing a suitable aliquot of plasma 
in 0.1 ml and 900 μl of freshly prepared FRAP reagent, 
prepared by mixing 10.0 ml of 22.78 mM sodium acetate 
buffer, pH 3.6, 1.0 ml of 20 mM ferric chloride and 1.0 ml of 10 
mM 2, 4, 6-tripyridyl-s-triazine solution prepared in 40 mM HCl. 
Before starting the reaction, both FRAP reagent and plasma 
samples were pre incubated for 5 min at 300C. Incubation was 
done for 5 min at 300C and absorbance was recorded at 593 
nm against a reagent blank in a Beckman DU 640 
spectrophotometer. Ferrous sulphate was used as a standard 
for calculating the “total antioxidant power”. 
Antimicrobial activity:-The reference antibiotic (RA) 
Streptomycin, Crude protein extract (CPE), Partially purified 
protein fraction (PPPF), Purified protein fraction (PPF) was 
dissolved in dimethyl sulphoxide 10% v/v (DMSO) at 2 mg/ml. 
Whereas CPE, PPPF, and PPF were used at a concentration 
of 10 mg/ml and further serial dilution was done in 0.1 M 
sodium acetate buffer pH 5.0 each. 
Hole diffusion method:-Screening test for antimicrobial 
activity were carried out by the hole diffusion method [23] by 
using a cell suspension from the pure culture of about 1.0 × 
104 colony forming unit (CFU)/ml obtained by McFarland 
turbidity standard number 0.5. The concentration of 
Amir Khan et al. /Rec Res Sci Tech 3 (2011) 07-12 
 
  
 9
suspension was standardized by taking the OD to 0.1 at 600 
nm (Beckman DV 640 Spectrophotometer). Holes of about 3 
mm diameter were made on the MHA plate and tilted with the 
100 µl (20 mg/ml, 10 mg/ml, 1 mg/ml, 0.1 mg/ml) of CPE, 
PPPF, PPF and RA.  
Results 
As seen in Figure 1 and Table 1 depicts the antioxidant 
impact of Crude protein extract (CPE), partially purified protein 
fraction (PPPF) and Purified protein fraction (PPF) at different 
concentration range 5-1000 µg/ml protein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Antioxidant activity (nmol/mg protein) of Crude protein 
extract (CPE), Partially purified protein fraction (PPPF) and Purified 
protein fraction (PPF) isolated from the roots of Boerhaavia diffusa. All 
values are mean ± Standard deviation of triplicate values, Significant 
for CPE at a P<0.05 and b P<0.01 
 
Table 1: Antioxidant activity (nmol/mg protein) of Crude protein extract (CPE), Partially purified protein fraction (PPPF) and Purified protein fraction 
(PPF) isolated from the roots of Boerhaavia diffusa 
Test Sample Protein 
(5 µg/ml) 
Protein 
(50 µg/ml) 
Protein 
(100µg/ml) 
Protein 
(200µg/ml) 
Protein 
(500µg/ml) 
Protein 
(1000µg/ml) 
CPE 
(nmol/mg) 
0.321±.003 0.362±.004 0.392±.003 0.462±.023 0.536±.032 0.622±.042 
PPPF 
(nmol/mg) 
0.862±.004 
(62.76%) 
0.901±.062 
(59.82%) 
1.02±.039 
(61.56%) 
1.13±.062 
(59.11%) 
1.32±.023 
(59.39%) 
1.46±.052 
(57.39%) 
PPF 
(nmol/mg) 
1.64±.031 
(80.42%) 
1.85±.053 
(80.43%) 
1.91±.065 
(79.47%) 
1.93±.072 
(76.06%) 
1.94±.059 
(72.37%) 
1.96±.092 
(68.26%) 
 
The results obtained, Purified protein fraction (PPF) was 
more efficient scavengers of peroxyl radicals. It was observed 
that the antioxidant power (Scavengers of peroxyl radicals) of 
PPF (100 µg/ml), PPPF (100 µg/ml) and CPE (100 µg/ml), 
there is a decrement of 1.96 nmol/mg1.46 nmol/ml0.622 
nmol/mg, respectively. Purified protein fractions (PPF) provide 
a high antioxidant activity than compared to PPPF and CPE as 
shown in Table 1. The hole diffusion method results are 
presented in Figure 2, shows the antioxidant activity as in the 
form of visible bacterial zone formation. There is no bacterial 
inhibition zone formation, without the application of either crude 
extract or its purified fractions. It was found that on application 
of 100 µg CPE (20 mg/ml), on inoculated MH media plate, the 
inhibition area correspond of 39.62 mm2 in CPE, whereas an 
application of PPP  and PP Fractions it was 176.56 and 329.25 
mm2 respectively. It is clear from the data that inhibition zone 
area, obtained from PPPF, was increased by 77.56 % than 
CPE applied plates, whereas 87.97% increment was observed 
when compared with PPF applied plates. On further dilution of 
the same CPE, PPPF and PPF fractions the same pattern was 
obtained. The inhibition zone area was increased by 89.90%, 
112.04%, 95.56% and 96.38%, than CPE compared to 
reference antibiotics (Streptomycin) applied plates as shown in 
Table 2. Thus the CPE, PPPF and PPF exhibited both 
antibacterial and antimicrobial effect, since the CPE, Protein 
fraction and RA were tested at different concentrations, the 
real extend of their inhibitory activities against the test micro 
organism (Mycobacterium scrofulaceum) can be well 
established only by comparing the minimal inhibitory 
concentration (MIC) values obtained. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Inhibition zone area*(mm2) for the Crude protein extract 
(CPE), partially purified protein fraction (PPPF) and Purified protein 
fraction (PPF) isolated from the roots of Boerhaavia diffusa and 
Reference antibiotic (RA) against Mycobacterium scrofulaceum. 
Inhibition zone area are mean (mm2) ± Standard deviation of triplicate 
values, *Inhibition zone area are calculated from the difference of 
radial of inhibition zone and hole (3 mm), **Reference antibiotics 
(Streptomycin), significantly different from CPE at a P<0.05, b P<0.01 
and c P<0.05 
 
Amir Khan et al. /Rec Res Sci Tech 3 (2011) 07-12 
 
  
 10
Table 2: Inhibition zone area*(mm2) for the Crude protein extract (CPE), Partially purified protein fraction (PPPF) and Purified protein fraction (PPF) 
isolated from the roots of Boerhaavia diffusa and Reference antibiotic (RA) against Mycobacterium scrofulaceum 
Test Sample Protein Conc./RA      (20 
mg/ml) 
Protein Conc./RA       
(10 mg/ml) 
Protein Conc./RA 
(1 mg/ml) 
Protein Conc./RA 
(0.1 mg/ml) 
 
CPE 
 
39.62±0.912 31.26±0.731 14.62±0.531 4.66±.625 
PPPF 
 
176.56±2.11 
(77.56%) 
162.53±2.63 
(80.76%) 
124.36±2.11 
(88.24%) 
73.12±1.22 
93.62%) 
PPF 
 
329.25±3.63 
(87.97%) 
316.75±4.12 
(90.13%) 
279.53±3.61 
(94.77%) 
163.53±2.11 
(97.15%) 
RA** 391.76±4.32 
(89.90%) 
 
381.51±3.13 
(112.04%) 
329.12±4.22 
(95.56%) 
267.19±2.69 
(96.38%) 
 
The Table 3 indicates the respective MIC values from 50-
1000 µg/ml for CPE and 5-1000 µg/ml for PPPF and PPF. The 
MICs of the CPE and its other functions on test pathogen was 
either greater or equal to that of RA. The results thus obtained, 
confirmed that Mycobacterium scrofulaceum was most 
sensitive organism to the isolated new INDIN-SAA crude 
protein extract and its purified protein fractions obtained from 
the roots of Boerhaavia diffusa.
  
Table 3: Minimal inhibitory concentration (MIC) µg/ml, Crude protein extract (CPE), Partially purified protein fraction (PPPF), Purified protein fraction 
(PPF), Inhibition zone area (- Absent, + Present, ++ Abundant, +++ Very abundant, NA- Not available) 
Test 
Sample 
Protein 
(5µg/ml 
Protein 
(10µg/ml 
Protein 
(50µg/ml 
Protein 
(100µg/ml 
Protein 
(200µg/ml 
Protein 
(400µg/ml 
Protein 
(800µg/ml 
Protein 
(1000µg/ml 
Without 
Protein 
CPE - - + ++ ++ ++ +++ +++ --- 
PPPF + + + ++ ++ ++ +++ +++ --- 
PPF + + + ++ +++ +++ +++ +++ --- 
RA + NA + ++ +++ +++ +++ +++  
 
The bacterial growth curve in term of optical density (OD) 
at 600 nm for different time interval (0-90 h) and two 
concentrations of CPE, PPPF and PPF (10 µg/ml and 20 
µg/ml) is shown in figure 3 and 4. It is observed that without 
the application of INDIN-SAA protein either CPE or PPF, the 
increase in O.D was observed, whereas on application of CPE 
and its purified fractions the maximal bacterial growth inhibition 
in term of decrement in O.D was noted. The maximal bacterial 
growth inhibition was found in PPF followed by PPPF and CPE 
in both concentrations (10 µg/ml and 20µg/ml) as shown in 
Table no 4, there is a decrement of 0.433 0.3140.102 and 
0.371 (CPE), 0.280 (PPPF), 0.086 (PPF), fold in both 
concentrations (10 µg/ml and 20 µg/ml) of CPE, PPPF and 
PPF, respectively. 
 
Table 4: Bacterial growth in term of Absorbance (600 nm), Crude protein extract (CPE) (10 µg/ml and 20 µg/ml), Partially purified protein fraction 
(PPPF) (10 µg/ml and 20 µg/ml), Purified protein fraction (PPF) (10 µg/ml and µg/ml) 
Time 
(h) 
INDIN-SAA 
Absent 
CPE PPPF PPF 
(10µg/ml) (20µg/ml) (10µg/ml) (20µg/ml) (10µg/ml) (20µg/ml) 
0 0.102±.002 0.103±.002 0.102±.003 0.103±.004 0.101±.007 0.102±.003 0.103±.004 
6 0.156±0.011 1.21±.003 1.29±.004 1.43±.005 1.51±.005 1.69±.005 1.73±.005 
12 0.193±0.005 1.13±.007 1.23±.005 1.29±.006 1.36±.002 1.43±.007 1.53±.004 
18 0.212±0.004 0.951±.005 0.926±.006 1.10±.008 0.931±.004 1.26±.005 1.10±.005 
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24 0.231±0.007 0.911±.009 0.851±.007 0.936±.007 0.851±.005 1.07±.004 0.961±.003 
36 0.352±0.004 0.863±.008 0.718±.007 0.729±.005 0.711±.007 0.862±.007 0.779±.004 
48 0.395±0.006 0.713±.007 0.675±.009 0.630±.007 0.581±.005 0.579±.008 0.511±.007 
60 0.412±0.002 0.618±.009 0.561±.007 0.536±.008 0.511±.007 0.370±.005 0.362±.008 
72 0.439±0.008 0.593±.007 0.537±.008 0.479±.007 0.445±.005 0.258±.021 0.211±.029 
90 0.477±0.005 0.524±.009 0.479±.009 0.450±.008 0.423±.007 0.172±.008 0.149±.007 
Fold 3.06 fold 0.433 fold 0.371 fold 0.314 fold 0.280 fold 0.102 fold 0.086 fold 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Mycobacterium scrofulaceum growth curve n term of 
absorbance at a different time intervals in absence of INDIN-SAA and 
presence of CPE (10 µg/ml), PPPF (10 µg/ml), PPF (10 µg/ml), 
Values are mean (OD) ± Standard deviation for bacterial growth for 
triplicate assay. 
 
 
 
 
 
 
 
 
 
 
Figure 4: Mycobacterium scrofulaceum growth curve n term of 
absorbance at a different time intervals in absence of INDIN-SAA and 
presence of CPE (20 µg/ml), PPPF (20 µg/ml), PPF (20 µg/ml), 
Values are mean (OD) ± Standard deviation for bacterial growth for 
triplicate assay. 
 
Discussion 
Boerhaavia diffusa is one of the most popular herbal 
remedies in India. Ayurvedic medicine that prescribes roots of 
Punarnava as diuretic, expectorant, vermifuge, analgesic used 
to improve the functions of kidney and liver [24]. In this study, it 
was observed that antimicrobial and anti-amyloproliferative 
activity of purified INDIN-SAA protein and its in-vitro on 
Mycobacterium scrofulaceum. We have made an attempt to 
provide basic approach for the evaluation of its traditional 
preparation in order to verify the therapeutic effect of the root 
extract in the form of isolated purified INDIN-SAA protein 
against the bacterium Mycobacterium scrofulaceum, as well as 
the disease Scrofula adenitis (Anjeerbal). Scrofula adenitis is a 
disease in which swelling of lymph nodes in neck or throughout 
body is seen in patients and disease is characterized by 
progressive painless enlargement of lymphoid tissue 
throughout the body. The increased frequency of the 
tuberculosis adenitis reflects a high incidence of the disease in 
India. The main causative agent of Scrofula adenitis is 
Mycobacterium scrofulaceum. To the best of our knowledge 
there are reports showing the efficacy of Boerhaavia diffusa 
products [25]. The PPF was more efficient scavengers of 
peroxyl radicals. It was observed that the antioxidant power of 
PPF, PPPF and CPE, there is a decrement of 1.96 1.46 
0.622 nmol/mg protein, respectively. Thus, Purified protein 
fraction (PPF) show high antioxidant activity than compared to 
PPPF and PPF. On the other hand, the MICs of the extracts 
and its fractions observed against the sensitive strain of 
Mycobacterium scrofulaceum, ranged from 5-1000 µg/ml, the 
values were equally effective to R.A. It was further observed 
that the antimicrobial activity was increased gradually as on 
application with CPE followed by PPPF and PPF. This 
antimicrobial activity may be due to alkaloids, phenols, 
polyphenols, tannins, triterpenes and steroids which were 
found in crude INDIN-SAA protein and its purified fractions. 
This phytochemical growth was known to cause antibacterial 
activities [26]. It was observed that the bacterial growth in term 
of Optical Density (at 600 nm) was increased by 3.06 fold 
without application of INDIN-SAA protein whereas on addition 
of Crude protein extract (CPE), Partially purified protein 
fraction (PPPF) and Purified protein fraction (PPE) (10 µg/ml 
and 20 µg/ml), there is a decrement of 0.4430.3140.102 
fold and 0.3710.2800.086 fold, respectively. Further 
purification and characterization of the active principal 
compounds from CPE and its purified fractions will provide a 
better antioxidant, antimicrobial and antilymphoproliferative 
mechanism. In conclusion, the crude INDIN-SAA protein 
extract and its purified fraction obtained from the roots of 
Boerhaavia diffusa were found to be active enough for the 
antimicrobial and antilymphoproliferative activity against the 
pathogen Mycobacterium scrofulaceum. Thus the result of this 
study could provide efficacious and cost effective treatment of 
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the Scrofula adenitis without any harmful effects on human 
body. 
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